Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts
Authors:
- 1 November 2019
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 20 (11) , e637-e644
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 31 references indexed in Scilit:
- Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceClinical Infectious Diseases, 2016
- Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort studyThe Lancet Oncology, 2016
- Human Papillomavirus Vaccination at a Time of Changing Sexual BehaviorEmerging Infectious Diseases, 2016
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in WomenNew England Journal of Medicine, 2015
- Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2014 and updates on immunizationIndian Pediatrics, 2014
- Is human papillomavirus vaccination likely to be a useful strategy in India?South Asian Journal of Cancer, 2013
- Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensivenessJournal of the Royal Society of Medicine, 2012
- Prevalence of human papillomavirus types in cervical lesions from women in rural Western IndiaJournal of Medical Virology, 2012
- Education and cancer incidence in a rural population in south IndiaCancer Epidemiology, 2009
- Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in IndiaBritish Journal of Cancer, 2008